Integrin
Intergrin is a cell adhesion receptor for extracellular matrix protein binding. It is also involved in cell to cell interaction and triggers a variety of signaling pathways for cell proliferation, survival and mobility etc.
Products Related to Integrin(122)
- GC70223Fradafiban hydrochloridePurity: >99.00%
Fradafiban (BIBU-52) hydrochloride is a nonpeptide platelet glycoprotein IIb/IIIa antagonist, which binds to the human platelet GP IIb/IIIa complex with a Kd value of 148 nM.
- GC70986Egaptivon pegol sodiumPurity: >92.00%
Egaptivon pegol sodium is an aptamer, which blocks binding of the von Willebrand Factor (VWF) to platelet GPIb receptors.
- GC72366VolociximabCAS: 558480-40-3Purity: >95.50%
Volociximab (M200) is a chimeric human/murine IgG4 antibody IIA1 targeting integrin α5β1 (EC50=0.2 nM).
- GC72461RovelizumabCAS: 339086-79-2Purity: >97.00%
Rovelizumab is a humanized monoclonal leukointegrin antibody.
- GC73519BT200 sodiumPurity: >98.00%
BT200 sodium, a pegylated form of the aptamer BT100, inhibits binding of von Willebrand factor (VWF) to platelet glycoprotein GPIb, preventing arterial thrombosis.
- GC74342Obtustatin triacetatePurity: >99.00%
Obtustatin triacetate is a 41-residue non-RGD disintegrin.
- GC74395Synstatin (92-119)CAS: 1259384-47-8Purity: >97.00%
Synstatin (92-119) is an anti-tumor agent that inhibits angiogenesis and cancer cell invasion.
- GC74401cRGDfK-thioacetyl ester TFAPurity: >99.00%
cRGDfK-thioacetyl ester TFA is a bioactive polypeptide molecule. cRGDfK peptide has a selective affinity for integrins. cRGDfK peptide can modify NIR fluorescent probes for cancer targeting imaging.
- GC74470VeltuzumabCAS: 728917-18-8Purity: >99.00%
Veltuzumab (IMMU-106) is a humanized anti-CD20 monoclonal antibody.
- GC747102-Methylbutyrylcarnitine chloridePurity: >98.00%
2-Metlbutyrylcarnitine (chloride) is a gut microbial metabolite which binds to integrin α2β1 in platelets, potentiating cytosolic phospholipase A2 (cPLA2) activation and platelet perresponsiveness.
- GC79131FurtisetabartCAS: 3055975-56-6Purity: >99.00%
Furtisetabart is a humanized monoclonal antibody targeting CD147 with anti-tumor activity.
- GC79132Fibronectin sctive fragment control acetatePurity: >99.00%
Fibronectin active fragment control acetate is an active peptide fragment of fibronectin.
- GC79133α4β7 Integrin-IN-2CAS: 2640360-68-3Purity: >98.00%
α4β7 Integrin-IN-2 is an inhibitor of human α4β7 integrin with an IC 50 <5 nM.
- GC79136Deethyl-emvistegrast TFAPurity: >98.50%
Deethyl-emvistegrast TFA is a quinoline derivative and also a α4β7 integrin inhibitor.
- GC79137C16Y acetatePurity: >98.50%
C16Y acetate is a short peptide and an inhibitor of integrins αvβ3 and α5β1.
- GC79140Cyclo(-RGDfK), 5/6 FAM labeled TFAPurity: >98.00%
Cyclo(-RGDfK), 5/6 FAM labeled TFA is a Cyclo(-RGDfK) TFA labeled with 5/6 FAM.
- GC79141T7 Peptide TFAPurity: >98.00%
T7 Peptide TFA is a protein synthesis inhibitor and anti-angiogenic agent, with a K d of 10 nM for human transferrin receptor.
- GC79995(S,R)-EmvistegrastCAS: 2417307-56-1Purity: >98%
(S,R)-Emvistegrast ((S,R)-GS-1427) is an isomer of Emvistegrast.
- GC81556FZ1 peptidePurity: >99.50%
FZ1 peptide is a cyclic heptapeptide and also an integrin αvβ3 agonist.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC70223 | Fradafiban hydrochloride | - | >99.00% | |
Fradafiban (BIBU-52) hydrochloride is a nonpeptide platelet glycoprotein IIb/IIIa antagonist, which binds to the human platelet GP IIb/IIIa complex with a Kd value of 148 nM. | ||||
| GC70986 | Egaptivon pegol sodium | - | >92.00% | |
Egaptivon pegol sodium is an aptamer, which blocks binding of the von Willebrand Factor (VWF) to platelet GPIb receptors. | ||||
| GC72366 | Volociximab | 558480-40-3 | >95.50% | |
Volociximab (M200) is a chimeric human/murine IgG4 antibody IIA1 targeting integrin α5β1 (EC50=0.2 nM). | ||||
| GC72461 | Rovelizumab | 339086-79-2 | >97.00% | |
Rovelizumab is a humanized monoclonal leukointegrin antibody. | ||||
| GC73519 | BT200 sodium | - | >98.00% | |
BT200 sodium, a pegylated form of the aptamer BT100, inhibits binding of von Willebrand factor (VWF) to platelet glycoprotein GPIb, preventing arterial thrombosis. | ||||
| GC74342 | Obtustatin triacetate | - | >99.00% | |
Obtustatin triacetate is a 41-residue non-RGD disintegrin. | ||||
| GC74346 | A20FMDV2 | 932699-03-1 | >98.00% | |
A20FMDV2 is a selective αvβ6 integrin inhibitor (IC50: 3 nM), with an activity 1,000-fold more selective for αvβ6 than for other RGD-directed integrins (αvβ3, αvβ5, and α5β1). | ||||
| GC74395 | Synstatin (92-119) | 1259384-47-8 | >97.00% | |
Synstatin (92-119) is an anti-tumor agent that inhibits angiogenesis and cancer cell invasion. | ||||
| GC74401 | cRGDfK-thioacetyl ester TFA | - | >99.00% | |
cRGDfK-thioacetyl ester TFA is a bioactive polypeptide molecule. cRGDfK peptide has a selective affinity for integrins. cRGDfK peptide can modify NIR fluorescent probes for cancer targeting imaging. | ||||
| GC74470 | Veltuzumab | 728917-18-8 | >99.00% | |
Veltuzumab (IMMU-106) is a humanized anti-CD20 monoclonal antibody. | ||||
| GC74710 | 2-Methylbutyrylcarnitine chloride | - | >98.00% | |
2-Metlbutyrylcarnitine (chloride) is a gut microbial metabolite which binds to integrin α2β1 in platelets, potentiating cytosolic phospholipase A2 (cPLA2) activation and platelet perresponsiveness. | ||||
| GC79131 | Furtisetabart | 3055975-56-6 | >99.00% | |
Furtisetabart is a humanized monoclonal antibody targeting CD147 with anti-tumor activity. | ||||
| GC79132 | Fibronectin sctive fragment control acetate | - | >99.00% | |
Fibronectin active fragment control acetate is an active peptide fragment of fibronectin. | ||||
| GC79133 | α4β7 Integrin-IN-2 | 2640360-68-3 | >98.00% | |
α4β7 Integrin-IN-2 is an inhibitor of human α4β7 integrin with an IC 50 <5 nM. | ||||
| GC79134 | GREDVGC | 1810716-06-3 | >99.00% | |
GREDVGC is a peptide. | ||||
| GC79135 | c-RGD-SH TFA | - | >98.50% | |
c-RGD-SH TFA is an Integrin αvβ3 ligand. | ||||
| GC79136 | Deethyl-emvistegrast TFA | - | >98.50% | |
Deethyl-emvistegrast TFA is a quinoline derivative and also a α4β7 integrin inhibitor. | ||||
| GC79137 | C16Y acetate | - | >98.50% | |
C16Y acetate is a short peptide and an inhibitor of integrins αvβ3 and α5β1. | ||||
| GC79140 | Cyclo(-RGDfK), 5/6 FAM labeled TFA | - | >98.00% | |
Cyclo(-RGDfK), 5/6 FAM labeled TFA is a Cyclo(-RGDfK) TFA labeled with 5/6 FAM. | ||||
| GC79141 | T7 Peptide TFA | - | >98.00% | |
T7 Peptide TFA is a protein synthesis inhibitor and anti-angiogenic agent, with a K d of 10 nM for human transferrin receptor. | ||||
| GC79995 | (S,R)-Emvistegrast | 2417307-56-1 | >98% | |
(S,R)-Emvistegrast ((S,R)-GS-1427) is an isomer of Emvistegrast. | ||||
| GC81350 | THR-123 TFA | - | >99.50% | |
THR-123 TFA is an orally active ALK3 peptide agonist. | ||||
| GC81556 | FZ1 peptide | - | >99.50% | |
FZ1 peptide is a cyclic heptapeptide and also an integrin αvβ3 agonist. | ||||
| GC81830 | D-RGDW acetate | - | >98.00% | |
D-RGDW acetate is an Arg-Gly-Asp (RGD) containing peptide. | ||||
